De Jong PE - Search Results

1

Do severe systemic sequelae of proteinuria modulate the antiproteinuric response to chronic ACE inhibition?

Bos H, Henning RH, De Jong PE, De Zeeuw D, Navis G. Bos H, et al. Among authors: de jong pe, de zeeuw d. Nephrol Dial Transplant. 2002 May;17(5):793-7. doi: 10.1093/ndt/17.5.793. Nephrol Dial Transplant. 2002. PMID: 11981065

2

Chronic angiotensin II infusion but not bradykinin blockade abolishes the antiproteinuric response to angiotensin-converting enzyme inhibition in established adriamycin nephrosis.

Wapstra FH, Navis G, DE Jong PE, DE Zeeuw D. Wapstra FH, et al. Among authors: de jong pe, de zeeuw d. J Am Soc Nephrol. 2000 Mar;11(3):490-496. doi: 10.1681/ASN.V113490. J Am Soc Nephrol. 2000. PMID: 10703672

3

Addition of AT1 blocker fails to overcome resistance to ACE inhibition in adriamycin nephrosis.

Bos H, Henning RH, De Boer E, Tiebosch AT, De Jong PE, De Zeeuw D, Navis G. Bos H, et al. Among authors: de jong pe, de zeeuw d, de boer e. Kidney Int. 2002 Feb;61(2):473-80. doi: 10.1046/j.1523-1755.2002.00154.x. Kidney Int. 2002. PMID: 11849387 Free article.

4

Dual renin-angiotensin system blockade at optimal doses for proteinuria.

Laverman GD, Navis G, Henning RH, de Jong PE, de Zeeuw D. Laverman GD, et al. Among authors: de jong pe, de zeeuw d. Kidney Int. 2002 Sep;62(3):1020-5. doi: 10.1046/j.1523-1755.2002.00536.x. Kidney Int. 2002. PMID: 12164886 Free article. Clinical Trial.

5

Renoprotective effects of VPI versus ACEI in normotensive nephrotic rats on different sodium intakes.

Laverman GD, Van Goor H, Henning RH, De Jong PE, De Zeeuw D, Navis G. Laverman GD, et al. Among authors: de jong pe, de zeeuw d. Kidney Int. 2003 Jan;63(1):64-71. doi: 10.1046/j.1523-1755.2003.00708.x. Kidney Int. 2003. PMID: 12472769 Free article.

6

Involvement of renal ACE activity in proteinuria-associated renal damage in untreated and treated adriamycin nephrotic rats.

Bos H, Laverman GD, Henning RH, Tiebosch AT, de Jong PE, de Zeeuw D, Navis G. Bos H, et al. Among authors: de jong pe, de zeeuw d. J Renin Angiotensin Aldosterone Syst. 2003 Jun;4(2):106-12. doi: 10.3317/jraas.2003.010. J Renin Angiotensin Aldosterone Syst. 2003. PMID: 12806593 Free article.

7

Enhanced responses of blood pressure, renal function, and aldosterone to angiotensin I in the DD genotype are blunted by low sodium intake.

van der Kleij FGH, de Jong PE, Henning RH, de Zeeuw D, Navis G. van der Kleij FGH, et al. Among authors: de jong pe, de zeeuw d. J Am Soc Nephrol. 2002 Apr;13(4):1025-1033. doi: 10.1681/ASN.V1341025. J Am Soc Nephrol. 2002. PMID: 11912262 Clinical Trial.

8

Targeting of doxorubicin to the urinary bladder of the rat shows increased cytotoxicity in the bladder urine combined with an absence of renal toxicity.

Haas M, Moolenaar F, Elsinga A, Van der Wouden EA, de Jong PE, Meijer DK, de Zeeuw D. Haas M, et al. Among authors: de jong pe, de zeeuw d. J Drug Target. 2002 Feb;10(1):81-9. doi: 10.1080/10611860290007568. J Drug Target. 2002. PMID: 11996090

9

High-dose ACE inhibition: can it improve renoprotection?

Navis G, Kramer AB, de Jong PE. Navis G, et al. Among authors: de jong pe. Am J Kidney Dis. 2002 Sep;40(3):664-6. doi: 10.1053/ajkd.2002.36005. Am J Kidney Dis. 2002. PMID: 12200823 Review. No abstract available.

10

Effects of anti-proteinuric therapy with angiotensin-converting-enzyme inhibition on renal protein catabolism in the adriamycin-induced nephrotic rat.

Haas M, de Boer E, de Jong PE, Moolenaar F, Meijer DK, de Zeeuw D. Haas M, et al. Among authors: de jong pe, de zeeuw d, de boer e. Clin Sci (Lond). 2003 Jul;105(1):51-7. doi: 10.1042/CS20020205. Clin Sci (Lond). 2003. PMID: 12636872

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

454 results

Search Page

Filters